title: [Anti-measles humoral immunity in children with thymus hyperplasia].
abstract: Analysis is made of the data obtained during clinical studies of the vaccinal process in 54 children with grades I-II thymus enlargement, vaccinated against measles. The clinical course of the vaccinal process in these children does not differ from the common course in normal children vaccinated against measles. The children with grades I-II thymus enlargement are capable of producing humoral antiviral immunity and of preserving high titres of antiviral antibodies for a long time.
authors.forename: E B
authors.initials: EB
authors.lastname: Gurvich
authors.forename: N V
authors.initials: NV
authors.lastname: Lysenkova
authors.forename: S N
authors.initials: SN
authors.lastname: Shishatskaia
authors.forename: P D
authors.initials: PD
authors.lastname: Vaganov
authors.forename: N A
authors.initials: NA
authors.lastname: Ozeretskovskiĭ
mesh_terms: D000293:Adolescent; D000914:Antibodies, Viral / Q000032:analysis*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D008457:Measles / Q000276:immunology / Q000517:prevention & control*; D008458:Measles Vaccine / Q000276:immunology*; D008459:Measles virus / Q000276:immunology*; D013952:Thymus Hyperplasia / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D008458:Measles Vaccine
vernacular_title: Protivokorevoĭ gumora'lnyĭ immunitet u deteĭ s uvelichennoĭ vilochkovoĭ zhelezoĭ.